X
API Suppliers
US DMFs Filed
CEP/COS Certifications
0
JDMFs Filed
0
Other Certificates
0
Other Suppliers
0
USA (Orange Book)
Europe
Canada
Australia
South Africa
0
Uploaded Dossiers
0
U.S. Medicaid
Annual Reports
0
https://www.prnewswire.com/news-releases/us-fda-approves-gattex-teduglutide-for-children-1-year-of-age-and-older-with-short-bowel-syndrome-sbs-300852294.html
https://news.bloomberglaw.com/pharma-and-life-sciences/shire-moves-to-protect-gattex-from-par-generic-challenge?context=landing-heroes
https://www.pharmacompass.com/pdf/news/gattex-teduglutide-amlodipine-and-valsartan-tabs-shire-nps-pharm-v-par-pharma-et-al-1533038693.pdf
http://www.pharmatimes.com/news/smc_endorses_five_new_therapies_for_nhs_scotland_1231056
https://www.pharmacompass.com/pdf/news/fda-confirms-paragraph-iv-patent-challenge-of-gattex-teduglutide-injection-1520057039.pdf
http://www.pharmatimes.com/news/nice_turns_down_shires_revestive_for_bowel_condition_1211408
https://www.pharmacompass.com/pdf/news/gattex-teduglutide-shire-nps-pharma-v-ambiopharm-par-pharmaceutical-1494838994.pdf
http://www.prnewswire.com/news-releases/shire-receives-extension-of-market-authorization-in-europe-for-revestive-teduglutide-for-the-treatment-of-paediatric-patients-with-short-bowel-syndrome-sbs-585798821.html
http://www.prnewswire.com/news-releases/shire-receives-positive-chmp-opinion-in-europe-for-revestive-teduglutide-for-paediatric-patients-with-short-bowel-syndrome-581070321.html
http://www.fiercepharma.com/story/drugmakers-congress-you-want-patent-reforms-stop-pharma-challenger-bass/2015-05-05
http://www.fiercepharma.com/story/shires-lialda-gattex-are-hedge-funders-latest-patent-targets/2015-04-06
Market Place
Share 
